drugset / Trial / NCT00705770

A Multi-Dose Study With a Treatment for Open-Angle Glaucoma

NCT00705770

Phase 2/3 Withdrawn Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether Anecortave Acetate is effective for lowering intraocular pressure caused by open-angle glaucoma.

Timeline

Start
2008-05
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Anecortave Acetate Small molecule

Indications